Table 1.
Variables | Train, (n = 129) | Validation, (n = 32) | Test, (n = 46) |
---|---|---|---|
Sex | |||
Male | 111 (86) | 29 (91) | 40 (87) |
Female | 18 (14) | 3 (9) | 6 (13) |
Age, year | 61 ± 12 | 61 ± 14 | 62 ± 10 |
Median interval between two scans, day | 53 | 52 | 56.5 |
Status | |||
Deceased | 83 (64) | 23 (72) | 32 (70) |
Censored | 46 (36) | 9 (28) | 14 (30) |
Median survival time, day | 467 | 475 | 488 |
Differentiation type | |||
Highly differentiated | 18 (14) | 4 (13) | 7 (15) |
Moderately differentiated | 100 (78) | 20 (63) | 34 (74) |
Low differentiated | 10 (8) | 8 (25) | 5 (11) |
Undifferentiated | 1 (1) | 0 (0) | 0 (0) |
NASH/NAFLD | |||
Yes | 26 (20) | 3 (9) | 6 (13) |
No | 103 (80) | 29 (91) | 40 (87) |
Surgery | |||
Yes | 67 (52) | 17 (53) | 25 (54) |
No | 62 (48) | 15 (47) | 21 (46) |
PVTT | |||
Yes | 24 (19) | 5 (16) | 7 (15) |
No | 105 (81) | 27 (84) | 39 (85) |
EBRT | |||
Yes | 6 (5) | 2 (6) | 2 (4) |
No | 123 (95) | 30 (94) | 44 (96) |
TAE/TACE | |||
Yes | 74 (57) | 20 (63) | 27 (59) |
No | 55 (43) | 12 (38) | 19 (41) |
RFA/WMA | |||
Yes | 38 (29) | 8 (25) | 12 (26) |
No | 91 (71) | 24 (75) | 34 (74) |
NASH non-alcoholic steatohepatitis, NAFLD non-alcoholic fatty liver disease, PVTT partial or complete portal vein tumor thrombosis, EBRT external beam radiation therapy, TAE transarterial embolization, TACE transarterial chemoembolization, RFA radiofrequency ablation, MWA microwave ablation